These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25721678)

  • 41. Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.
    Deville C; Vapiwala N; Hwang WT; Lin H; Ad VB; Tochner Z; Both S
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1389-96. PubMed ID: 21664069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter Study.
    Archer P; Marvaso G; Detti B; Colombo F; Francolini G; Vandendorpe B; Thananayagam MA; Baty M; De Crevoisier R; Alongi F; Nicosia L; Scher N; Toledano A; Di Muzio N; Fodor A; Zilli T; Franzese C; Scorsetti M; Shelan M; Triggiani L; Aymes E; Le Deley MC; Jereczek-Fossa BA; Pasquier D
    Eur Urol Oncol; 2023 Jun; 6(3):303-310. PubMed ID: 37012102
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Salvage external beam radiotherapy for prostate cancer biochemical recurrence after radical prostatectomy].
    Martín FL; García PD
    Arch Esp Urol; 2012; 65(1):131-44. PubMed ID: 22318184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ferumoxtran-10 MR lymphography for target definition and follow-up in a patient undergoing image-guided, dose-escalated radiotherapy of lymph nodes upon PSA relapse.
    Weidner AM; van Lin EN; Dinter DJ; Rozema T; Schoenberg SO; Wenz F; Barentsz JO; Lohr F
    Strahlenther Onkol; 2011 Mar; 187(3):206-12. PubMed ID: 21347637
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Robot-assisted Placement of Pelvic Tissue Expander for Radiation After Prostatectomy and Cystectomy for Treatment of Prostate Cancer Biochemical Recurrence.
    Quarrier SO; Matloubieh JE; Wu G
    Urology; 2019 Feb; 124():292-296. PubMed ID: 30385261
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder.
    Sanguineti G; Castellone P; Foppiano F; Franzone P; Marcenaro M; Tognoni P; Bolognesi A; Ceresoli GL; Fiorino C
    Strahlenther Onkol; 2004 Sep; 180(9):563-72. PubMed ID: 15378187
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neoadjuvant hormone therapy before salvage radiotherapy for an increasing post-radical prostatectomy serum prostate specific antigen level.
    Tiguert R; Rigaud J; Lacombe L; Laverdière J; Fradet Y
    J Urol; 2003 Aug; 170(2 Pt 1):447-50. PubMed ID: 12853796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Salvage 125I brachytherapy of locally recurrent prostate cancer].
    Gesztesi L; Ágoston P; Major T; Gődény M; Andi J; Lengyel Z; Polgár C
    Magy Onkol; 2014 Sep; 58(3):219-24. PubMed ID: 25260087
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Salvage image-guided intensity modulated or stereotactic body reirradiation of local recurrence of prostate cancer.
    Zerini D; Jereczek-Fossa BA; Fodor C; Bazzani F; Maucieri A; Ronchi S; Ferrario S; Colangione SP; Gerardi MA; Caputo M; Cecconi A; Gherardi F; Vavassori A; Comi S; Cambria R; Garibaldi C; Cattani F; De Cobelli O; Orecchia R
    Br J Radiol; 2015 Aug; 88(1052):20150197. PubMed ID: 26055506
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients.
    Cozzarini C; Montorsi F; Fiorino C; Alongi F; Bolognesi A; Da Pozzo LF; Guazzoni G; Freschi M; Roscigno M; Scattoni V; Rigatti P; Di Muzio N
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):966-74. PubMed ID: 19619960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-dose-rate brachytherapy for prostate cancer in a previously radiated patient with polyethylene glycol hydrogel spacing to reduce rectal dose: case report and review of the literature.
    Nguyen PL; Devlin PM; Beard CJ; Orio PF; O'Leary MP; Wolfsberger LD; O'Farrell DA; Sweeney CM; Hadaschik BA; Hohenfellner M; Hatiboglu G
    Brachytherapy; 2013; 12(1):77-83. PubMed ID: 22543116
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Salvage low-dose-rate brachytherapy for prostate cancer local recurrence after radical prostatectomy: our first three patients.
    Gastaldi E; Gallo F; Chiono L; Giberti C
    Urologia; 2014; 81(1):46-50. PubMed ID: 24474541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Significance of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgery.
    Chang JH; Park W; Park JS; Pyo H; Huh SJ; Choi HY; Lee HM; Jeon SS; Seo SI
    Int J Urol; 2015 Jan; 22(1):82-7. PubMed ID: 25208624
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer.
    King CR; Brooks JD; Gill H; Presti JC
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):877-82. PubMed ID: 21300474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of changing rectal dose volume parameters over time on late rectal and urinary toxicity after high-dose intensity-modulated radiotherapy for prostate cancer: A 10-years single centre experience.
    Fonteyne V; Sadeghi S; Ost P; Vanpachtenbeke F; Vuye P; Lumen N; De Meerleer G
    Acta Oncol; 2015 Jun; 54(6):854-61. PubMed ID: 25387271
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Radiotherapy for local recurrences of prostate cancer after radical prostatectomy].
    Grishina YA; Khmelevsky EV
    Vopr Onkol; 2015; 61(1):7-13. PubMed ID: 26016138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Feasibility and preliminary outcome of salvage combined HDR brachytherapy and external beam radiotherapy (EBRT) for local recurrences after radical prostatectomy.
    Niehoff P; Loch T; Nürnberg N; Galalae R; Egberts J; Kohr P; Kovács G
    Brachytherapy; 2005; 4(2):141-5. PubMed ID: 15893268
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis.
    Bernard JR; Buskirk SJ; Heckman MG; Diehl NN; Ko SJ; Macdonald OK; Schild SE; Pisansky TM
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):735-40. PubMed ID: 19464818
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Salvage radiotherapy for biochemical recurrence after radical prostatectomy.
    Terai A; Matsui Y; Yoshimura K; Arai Y; Dodo Y
    BJU Int; 2005 Nov; 96(7):1009-13. PubMed ID: 16225518
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results.
    Ost P; Lumen N; Goessaert AS; Fonteyne V; De Troyer B; Jacobs F; De Meerleer G
    Eur Urol; 2011 Oct; 60(4):842-9. PubMed ID: 21514039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.